GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on Wednesday.
May 8 (Reuters) - Pfizer (PFE.N), opens new tab has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on ...
June 3 (Reuters) - Shares of GSK (GSK.L), opens new tab dropped more than 9% on Monday, after a Delaware judge allowed more than 70,000 lawsuits alleging its discontinued heartburn drug Zantac caused ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback